A surrogate consent committee may:
  (1) consent to the use of a psychoactive medication;
  (2) consent to the use of a highly restrictive procedure;
  (3) consent to major medical treatment;
  (4) consent to major dental treatment;
  (5) make a decision that involves risk to individual protection and rights; and
  (6) consent to release of records related to the individual's condition or treatment to facilitate the treatment to which the surrogate consent committee has consented.

Source Note: The provisions of this §261.288 adopted to be effective July 1, 2007, 32 TexReg 3856; transferred effective October 1, 2020, as published in the Texas Register August 28, 2020, 45 TexReg 6127